SCHEMBL24423857

SCHEMBL24423857

COc1cc(-c2cc(C(=O)N3CCC(C(=O)NCc4ccc(Cl)cn4)CC3)n[nH]2)c(Cl)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 3/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ KDM5A P29375 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMO Q99835 1/20 0.38
▸ NPY5R Q15761 1/20 0.38
▸ ACHE P22303 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29583151 1.00 EPHX2 (0.39) EPHX2MEN1KMT2ARECQLKDM5A
SCHEMBL24424599 0.94 MEN1 (0.40) EPHX2MEN1KMT2AKDM5ASMO
SCHEMBL29584093 0.94 MEN1 (0.40) EPHX2MEN1KMT2AKDM5ASMO
SCHEMBL24424028 0.92 ALDH1A1 (0.38) EPHX2MEN1KMT2AKDM5ASMO
SCHEMBL29584822 0.91 MAPT (0.40) EPHX2MEN1KMT2AKDM5ASMO
SCHEMBL29243798 0.91 MAPT (0.40) EPHX2MEN1KMT2AKDM5ASMO
SCHEMBL24424600 0.90 PRKAA2 (0.42) EPHX2MEN1KMT2APOLBBACE1
SCHEMBL30629615 0.90 PRKAA2 (0.42) EPHX2MEN1KMT2APOLBBACE1
SCHEMBL29584813 0.90 MEN1 (0.40) EPHX2MEN1KMT2ARECQLKDM5A
SCHEMBL29243423 0.90 MEN1 (0.40) EPHX2MEN1KMT2ARECQLKDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635380-A PPARgamma modulators and methods of use 卫材R&D管理有限公司 2023-08-22 — — CN claimed
CN-116635380-A PPARgamma modulators and methods of use 卫材R&D管理有限公司 2023-08-22 — — CN disclosed
US-20230062861-A1 PPARg MODULATORS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-03-02 — — US disclosed
WO-2022099144-A1 ΡΡΑRγ MODULATORS AND METHODS OF USE Eisai R&D Mangement Co., Ltd. (JP) 2022-05-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230062861-A1 PPARg MODULATORS AND METHODS OF USE PPARG, PPARA, PPARD EPHX2 3345/4885MEN1 4809/4885KMT2A 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback